China Law & Practice attended the Second Advanced China Summit on M&A at the end of last year. Strategy and the climate for M&A were high on the agenda, as well as vital lessons for getting the deal done

China has been gradually opening up to wholly foreign-owned medical institutions, but a lack of policies has made it impossible for foreign investors to tap this market. Finally, a framework is in place in Shanghai's Free Trade Zone

Design patents in Taiwan are becoming broader. This has opened up new opportunities for IP owners who want to maximise the protection available to them

Mainland investors in Taiwan have plenty of opportunities to succeed, as long as they follow a few key guidelines

Taiwan's Personal Data Protection Act contains several strict provisions relating to written consent requirements that affect foreign companies, even if they are not registered in the jurisdiction

Taiwan needs to reform its healthcare system. Europe and Japan have both set examples in the innovative use of private finance, but the government needs to be aware of the risks

Enforcing final civil judgments that have been made in mainland, Hong Kong and Macau courts in Taiwan can be challenging. As cross-strait disputes increase, businesses need to make sure they have the right dispute resolution clauses in place

The government has published a Bill proposing far-reaching changes to Taiwan's M&A environment. Businesses need to familiarise themselves with the possible changes and follow its progress carefully

C Y Huang, Chairman of the Taiwan Mergers & Acquisitions and Private Equity Council (MAPE), spoke to China Law and Practice about the hold up on the Cross-Strait Service Agreement and the effect this is having on deals